6-43451182-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_023932.4(DLK2):c.509G>A(p.Arg170His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000471 in 1,614,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_023932.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DLK2 | NM_023932.4 | c.509G>A | p.Arg170His | missense_variant | 6/6 | ENST00000372488.8 | NP_076421.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DLK2 | ENST00000372488.8 | c.509G>A | p.Arg170His | missense_variant | 6/6 | 1 | NM_023932.4 | ENSP00000361566.3 | ||
DLK2 | ENST00000357338.3 | c.509G>A | p.Arg170His | missense_variant | 6/6 | 2 | ENSP00000349893.3 | |||
DLK2 | ENST00000372485.5 | c.491G>A | p.Arg164His | missense_variant | 6/6 | 5 | ENSP00000361563.1 | |||
DLK2 | ENST00000430324.5 | c.224G>A | p.Arg75His | missense_variant | 3/3 | 2 | ENSP00000399829.1 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152166Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000481 AC: 12AN: 249652Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135142
GnomAD4 exome AF: 0.0000205 AC: 30AN: 1461870Hom.: 0 Cov.: 33 AF XY: 0.0000206 AC XY: 15AN XY: 727238
GnomAD4 genome AF: 0.000302 AC: 46AN: 152166Hom.: 0 Cov.: 33 AF XY: 0.000336 AC XY: 25AN XY: 74334
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 18, 2023 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at